Senti Biosciences's market cap is currently ―. The company's EPS TTM is $-1.601; its P/E ratio is -0.24; Senti Biosciences is scheduled to report earnings on May 7, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 338.00K	$ 937.00K	$ 1.29M	$ 662.00K	$ 1.52M
Gross Profit	$ 338.00K	$ 687.00K	$ 1.04M	$ 662.00K	-
EBIT	$ -42.41M	$ -18.75M	$ -18.68M	$ -29.82M	$ -17.09M
EBITDA	$ -40.69M	$ -17.97M	$ -18.29M	$ -29.18M	$ -16.05M
Net Income Common Stockholders	$ -42.41M	$ -18.70M	$ -18.68M	$ -28.69M	$ -16.64M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 39.43M	$ 59.63M	$ 76.11M	$ 98.56M	$ 114.94M
Total Assets	$ 131.77M	$ 143.63M	$ 161.43M	$ 180.79M	$ 189.44M
Total Debt	$ 37.31M	$ 38.24M	$ 37.92M	$ 37.09M	$ 34.09M
Net Debt	$ -2.12M	$ -21.39M	$ -38.18M	$ -61.47M	$ -80.84M
Total Liabilities	$ 48.83M	$ 46.21M	$ 49.09M	$ 53.53M	$ 49.10M
Stockholders Equity	$ 82.94M	$ 97.42M	$ 112.34M	$ 127.26M	$ 140.34M
Cash Flow	-
Free Cash Flow	$ -17.42M	$ -17.25M	$ 3.37M	$ -17.54M	$ -24.34M
Operating Cash Flow	$ -15.56M	$ -13.58M	$ 3.37M	$ -9.01M	$ -10.14M
Investing Cash Flow	$ 21.34M	$ 18.23M	$ -9.60M	$ -49.12M	$ -14.20M
Financing Cash Flow	$ -23.00K	$ 281.00K	$ -35.00K	$ 876.00K	$ -485.00K

Currency in USD

Senti Biosciences Earnings and Revenue History

Income Statement >

Senti Biosciences Debt to Assets

Balance Sheet >

Senti Biosciences Cash Flow

Cash Flow >

Senti Biosciences Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing